| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/30/2010 | WO2010111282A1 Anti-mesothelin antibodies |
| 09/30/2010 | WO2010111254A1 Novel anti-alpha5beta1 antibodies and uses thereof |
| 09/30/2010 | WO2010111198A1 Compounds compositions and methods of treating cancer and fibrotic diseases |
| 09/30/2010 | WO2010111180A1 Humanized antibodies against light and uses thereof |
| 09/30/2010 | WO2010110737A1 Monoclonal antibody against a conserved domain of m2e polypeptide in influenza viruses |
| 09/30/2010 | WO2010109924A1 Lh-type bispecific antibody |
| 09/30/2010 | WO2010109874A1 Koi herpes virus-specific antibody and antigen thereof |
| 09/30/2010 | WO2010109165A2 Binding molecules |
| 09/30/2010 | WO2010109042A1 Composition for the prevention or treatment of diabetes mellitus |
| 09/30/2010 | WO2010109010A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| 09/30/2010 | WO2010108977A1 Vaccine for protection against streptococcus suis bacteria of various serotypes |
| 09/30/2010 | WO2010108937A2 Drug fusions and conjugates |
| 09/30/2010 | WO2010108824A1 L-plastin antibodies and their use |
| 09/30/2010 | WO2010108665A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | WO2010108503A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | WO2010085682A3 Stabilized fc polypeptides with reduced effector function and methods of use |
| 09/30/2010 | WO2010084408A3 Pta089 protein |
| 09/30/2010 | WO2010076400A8 Use of an anti-cd20 antibody for treating primary intraocular lymphoma |
| 09/30/2010 | WO2010043977A3 Dengue virus neutralizing antibodies and uses thereof |
| 09/30/2010 | WO2010042562A3 Muc1* antibodies |
| 09/30/2010 | WO2010030813A3 Methods for inhibiting ocular angiogenesis |
| 09/30/2010 | US20100251427 Compositions and methods for producing plants with improved stress tolerance |
| 09/30/2010 | US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 09/30/2010 | US20100249385 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
| 09/30/2010 | US20100249383 Novel Ligand Involved In The Transmigration Of Leukocytes Across the Endothelium and Uses Therefor |
| 09/30/2010 | US20100249382 MODIFIED Fc MOLECULES |
| 09/30/2010 | US20100249381 Method for Purifying FC-Fusion Proteins |
| 09/30/2010 | US20100249380 Modulating Immune Responses |
| 09/30/2010 | US20100249379 Protein expression from multiple nucleic acids |
| 09/30/2010 | US20100249372 Botulinum neurotoxin a receptor and the use thereof |
| 09/30/2010 | US20100249209 Gene involved in immortalization of human cancer cell and use thereof |
| 09/30/2010 | US20100249039 Methods for Treating Cancer Using an Immunotoxin |
| 09/30/2010 | US20100249034 Gfralpha3 and its uses |
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100249029 Peptides with high affinity for the prolactin receptor |
| 09/30/2010 | US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins |
| 09/30/2010 | US20100248974 Crystal structure of cd147 extracellular region and use thereof |
| 09/30/2010 | US20100248305 Polyamino acid synthetase and gene encoding the same |
| 09/30/2010 | US20100248274 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 09/30/2010 | US20100248270 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease |
| 09/30/2010 | US20100248267 Method for measurement of concentration of antigen |
| 09/30/2010 | US20100248262 Anti-Fibronectin Fragment Monoclonal Antibody |
| 09/30/2010 | US20100248255 Novel peptides |
| 09/30/2010 | US20100248244 Characterization of ESM-1 as a Tumor Associated Marker of Colorectal Cancer |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100248234 Cancer diagnostic kit and cancer diagnostic method |
| 09/30/2010 | US20100248218 Conjugates, and use thereof in detection methods |
| 09/30/2010 | US20100248217 Roundworm coproantigen detection |
| 09/30/2010 | US20100248211 Method for analysis of hepatitis b virus s antigen |
| 09/30/2010 | US20100247657 Telomerase reverse transcriptase variant |
| 09/30/2010 | US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 09/30/2010 | US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 09/30/2010 | US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 09/30/2010 | US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE |
| 09/30/2010 | US20100247556 Method for activation of helper t cell and composition for use in the method |
| 09/30/2010 | US20100247555 Reversibly inhibited antibodies for immune cell stimulation |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247551 Use of Lipocalin 2 in the Regulation of Insulin Sensitivity |
| 09/30/2010 | US20100247550 Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| 09/30/2010 | US20100247549 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 09/30/2010 | US20100247546 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 09/30/2010 | US20100247545 Antibodies to m-csf |
| 09/30/2010 | US20100247542 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 09/30/2010 | US20100247541 novel antigen associated with the neovasculature of tumour metastases |
| 09/30/2010 | US20100247539 Antibodies that Inhibit Transport Activity of Peptide Transporters |
| 09/30/2010 | US20100247536 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 09/30/2010 | US20100247535 Chemically Programmable Immunity |
| 09/30/2010 | US20100247532 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 09/30/2010 | US20100247531 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | US20100247529 Cooperative and dynamic assembly of affinity complexes |
| 09/30/2010 | US20100247526 Anti-NKG2A Antibodies and Uses Thereof |
| 09/30/2010 | US20100247523 Subtypes of humanized antibody against interleuken-6 receptor |
| 09/30/2010 | US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247517 Use of mnk inhibitors for the treatment of alzheimer's disease |
| 09/30/2010 | US20100247515 Polypeptides, antibody variable domains and antagonists |
| 09/30/2010 | US20100247442 Macaca fascicularis ST2L |
| 09/30/2010 | US20100247431 Polypeptides including modified constant regions |
| 09/30/2010 | US20100247430 Methods and Compositions for Modulating T Cells |
| 09/30/2010 | CA2756853A1 Drug fusions and conjugates |
| 09/30/2010 | CA2756789A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 09/30/2010 | CA2756572A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | CA2756393A1 Anti-mesothelin antibodies |
| 09/30/2010 | CA2756186A1 Humanized antibodies against light and uses thereof |
| 09/30/2010 | CA2756171A1 Binding molecules |
| 09/30/2010 | CA2754393A1 Membrane evaporation for generating highly concentrated protein therapeutics |
| 09/30/2010 | CA2754163A1 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | CA2753988A1 Novel anti-.alpha.5.beta.1 antibodies and uses thereof |
| 09/30/2010 | CA2753388A1 Compounds compositions and methods of treating cancer and fibrotic diseases |
| 09/29/2010 | EP2233574A1 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/29/2010 | EP2233572A2 Genes and polypeptides relating to human colon cancers |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233503A1 Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 09/29/2010 | EP2233502A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| 09/29/2010 | EP2233501A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 09/29/2010 | EP2233500A1 Optimized Fc variants |
| 09/29/2010 | EP2233499A1 Antibody composition with altered Fab sialylation |
| 09/29/2010 | EP2233149A1 Combination of BLYS inhibition and anti-CD20 agents for treatment of autoimmune disease |
| 09/29/2010 | EP2231709A1 Bivalent, bispecific antibodies |